Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore

New Delhi: Pharma major Sun Pharmaceutical Industries reported a 59.19 percent dip in consolidated net profit to Rs 912.12 crore for the quarter ended on September 30, 2017, compared to the year-ago quarter.
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.
Consolidated total revenue from operations stood at Rs 6,650.34 crore. It was Rs 8,260.11 crore in the same period of previous year.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd